Technical Analysis for AGRX - Agile Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 1.58 -0.63% -0.01
AGRX closed down 0.63 percent on Wednesday, March 20, 2019, on 61 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical AGRX trend table...

Date Alert Name Type % Chg
Mar 20 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 20 Calm After Storm Range Contraction 0.00%
Mar 20 Outside Day Range Expansion 0.00%
Mar 20 Wide Bands Range Expansion 0.00%
Mar 20 Overbought Stochastic Strength 0.00%
Mar 20 Down 3 Days in a Row Weakness 0.00%
Mar 20 Down 4 Days in a Row Weakness 0.00%
Mar 20 Down 5 Days in a Row Weakness 0.00%
Mar 19 1,2,3 Pullback Bullish Bullish Swing Setup -0.63%

Older signals for AGRX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, a 28-day regimen, which provides a shortened hormone-free interval; and AG890, a levonorgestrel-only contraceptive patch for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.
Pharmaceutical Drugs Organic Compounds Alcohols Hormonal Contraception Medroxyprogesterone Acetate
Is AGRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.01
52 Week Low 0.23
Average Volume 636,959
200-Day Moving Average 0.6842
50-Day Moving Average 1.02
20-Day Moving Average 1.2381
10-Day Moving Average 1.5
Average True Range 0.1143
ADX 51.64
+DI 39.2201
-DI 7.5741
Chandelier Exit (Long, 3 ATRs ) 1.3571
Chandelier Exit (Short, 3 ATRs ) 1.2429
Upper Bollinger Band 1.8441
Lower Bollinger Band 0.6321
Percent B (%b) 0.78
BandWidth 97.891931
MACD Line 0.1885
MACD Signal Line 0.1536
MACD Histogram 0.0349
Fundamentals Value
Market Cap 45.51 Million
Num Shares 28.8 Million
EPS -0.97
Price-to-Earnings (P/E) Ratio -1.63
Price-to-Sales 0.00
Price-to-Book 4.55
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.73
Resistance 3 (R3) 1.74 1.69 1.71
Resistance 2 (R2) 1.69 1.66 1.69 1.70
Resistance 1 (R1) 1.64 1.63 1.62 1.63 1.69
Pivot Point 1.59 1.59 1.58 1.59 1.59
Support 1 (S1) 1.54 1.56 1.52 1.53 1.47
Support 2 (S2) 1.49 1.53 1.49 1.46
Support 3 (S3) 1.44 1.49 1.46
Support 4 (S4) 1.43